Phoenix-Micron, Inc. and ArtiKode Intelligence Collaborate to Bring Automated, AI-Powered OCT Segmentation to MICRON Software Suite Bend, OR, USA – April 23, 2024 – Phoenix-Micron, Inc. (“Phoenix”), recognized globally for its leadership in in vivo ophthalmic imaging of small animals, today announced a collaboration with ArtiKode Intelligence (“ArtiKode”), a Valencia, Spain-based innovator in artificial intelligence (AI)
11.07
2023
Researchers find early signs of Alzheimer’s disease (AD) in the mouse retina and develop a non-invasive artificial intelligence-based system that could be used to diagnose the disease before the appearance of clinical symptoms
Progress in diagnosing and treating Alzheimer’s disease (AD) has been accelerating over the last few years. Until now, AD has been difficult to diagnose. The disease can be present years before distinguishable symptoms manifest. Non-invasive diagnostic tests have been lacking, and diagnosis often relies on memory, cognitive, and behavioral tests. In 2011, Koronyo-Hamaoui M, Koronyo
19.01
2022
Deep learning provides unbiased evaluation of uveitis severity levels in 1500 Phoenix MICRON® mouse fundus images
In 2020, researchers Jian Sun, Xiaoqin Huang et al, in the Laboratory of Immunology at the National Eye Institute, confirmed in the lab what has been going on in human ophthalmology in recent years, but with a twist. Their deep learning model enabled identification of retinal disease stages with noteworthy accuracy. What marked their work